Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA
Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA. It won't just be for COPD anymore.
But don't expect to use it first-line for asthma.
Adding Spiriva to a medium-dose inhaled steroid may improve lung function similar to adding a long-acting beta-agonist (salmeterol, etc).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote